Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. - Wikidata - awgldk - TriplyDB

Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.

Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.

http://www.wikidata.org/entity/Q44752430

about

Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation Antioxidants and coronary artery disease: from pathophysiology to preventive therapy Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease 3-nitrotyrosine modified proteins in atherosclerosis Vascular biology of eicosanoids and atherogenesis Physicochemistry and cardiovascular toxicity of metal fume PM2.5: a study of human coronary artery endothelial cells and welding workers N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.Oxidative risk for atherothrombotic cardiovascular disease.Selective gamma-ketoaldehyde scavengers protect Nav1.5 from oxidant-induced inactivation.Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases.Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial.A urinary marker of oxidative stress covaries positively with hostility among midlife community volunteers.Improved method of plasma 8-Isoprostane measurement and association analyses with habitual drinking and smoking."Old" hearts and arteries: the role of oxidative stress Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans.Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis.Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease.Oxidative status and cardiovascular risk in women: Keeping pink at heart.Long-term effect of mediterranean-style diet and calorie restriction on biomarkers of longevity and oxidative stress in overweight men F2-isoprostanes as an indicator and risk factor for coronary heart disease.Lipid peroxidation and depressed mood in community-dwelling older men and women.Obesity, age, and oxidative stress in middle-aged and older women.Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study.Reactive oxygen species in cardiovascular disease.Increasing the vegetable intake dose is associated with a rise in plasma carotenoids without modifying oxidative stress or inflammation in overweight or obese postmenopausal women Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.A comparative study of time-specific oxidative stress after acute myocardial infarction in patients with and without diabetes mellitus Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations.Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial.Biomarkers of obesity and subsequent cardiovascular events Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial Cardiovascular pharmacology and physiology of the isoprostanes.Analysis of F2-isoprostanes in plasma of pregnant women by HPLC-MS/MS using a column packed with core-shell particles.LC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide.MnSOD and GPx1 polymorphism relationship with coronary heart disease risk and severity.Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study.F2-isoprostanes are correlated with trans fatty acids in the plasma of pregnant women.Association of polymorphisms in FADS gene with age-related changes in serum phospholipid polyunsaturated fatty acids and oxidative stress markers in middle-aged nonobese men.

P2860

Q26864770-E30060AB-D351-4AA8-BCED-1050ACBF18A3 Q27025669-4B8B3B05-680D-40D0-97BF-EC5E8AB9D446 Q27027247-83B039BE-3364-474D-9EAB-B6A8B8A54789 Q28083260-BF4A7BA6-36ED-405A-BBB9-1A005916563B Q28259045-DF0EA61C-F23B-404E-981A-C15A4E9EF1B0 Q28389592-AC25DA8F-A87A-4ACE-BF09-A93C854C73D5 Q28573358-D67F30F2-47F2-4345-9B46-298FE45698B6 Q30248995-CE7176CE-49BC-4A10-8F0B-7B915BF5F458 Q33554184-86EE3207-638C-44D0-8CD4-6757FF400E18 Q33638480-A56FAFA5-368E-4494-B3AE-989D08E132FE Q33702786-9295E869-0EDE-4EC7-8275-45DEB936D4A6 Q33759853-140ADFA0-9191-4C3E-8AFF-AA57D377B939 Q33906780-598436F0-40A1-4106-BD64-6813D692664B Q33909814-55296EDA-E50F-4432-BFBC-7EF8DC456815 Q34048544-072B710A-0EE0-4FAB-970A-4CC78893B8C4 Q34070498-C57E4B99-85A2-4580-88D8-B7946BB47081 Q34104339-A5341F71-B343-41BF-B354-F1013FE47309 Q34188057-13F60320-0D80-4AC3-9677-4F0CF7D973DF Q34389495-CA593162-DF13-4144-A85D-A680DB7BB3E1 Q34442801-DD103B71-D03A-4740-918E-6FFC90366FDF Q34684200-EECE918D-3132-43D4-96B3-73637A341C1C Q34775703-DE0FE2F7-6E07-449C-BB99-22E6C22C61EA Q34987129-10EC0EBA-6250-4B34-A9F8-829FC8CC889E Q35117192-0ED02E30-9F83-44EF-A27A-66BB13A63A38 Q35165194-0A7685C8-C91B-4BC6-A187-DB4D243E17F3 Q35217824-98B377A0-39C3-4867-A652-858DF48945D9 Q35838049-FEFD0D32-7D32-4E28-9960-3667A4D550F0 Q36024430-ACAF276F-A9FC-4E9D-8A23-3F1BED39F820 Q36027263-AFFA44AC-DC3C-42CF-AB23-EEB71CD757C2 Q36141348-B331BE63-0D2A-42B7-868C-0299C9851498 Q36258777-6F0F7E3B-AD27-49E8-B384-6D529C619209 Q36381096-5348978E-87EE-4459-863B-DCC902D94C00 Q36579767-367F4416-1A67-4E2D-92A6-C7032EEA47E7 Q36591716-651E64D9-DBAD-42B5-BC4B-997B459192A3 Q36754859-19F0C480-1F0C-452C-A2A1-86FFFBDB5CDE Q36790461-EF93B3ED-EE55-42CA-AD28-9BD6937FB8CA Q36790505-49D7030F-39EA-4EC2-AC46-AFC9539C80B8 Q36833592-872E73D4-98DD-4116-8D0C-16DDEBA0D552 Q36869239-1694A200-312E-4814-A96E-400CF68FE393 Q36957275-135FBFF7-7780-4F82-9F92-AEDC475F959D

P2860

Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.

http://www.wikidata.org/entity/Q44752430

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Urinary 8-iso-prostaglandin F2 ...... a matched case-control study.

@en

Urinary 8-iso-prostaglandin F2 ...... a matched case-control study.

@nl

type

label

Urinary 8-iso-prostaglandin F2 ...... a matched case-control study.

@en

Urinary 8-iso-prostaglandin F2 ...... a matched case-control study.

@nl

prefLabel

Urinary 8-iso-prostaglandin F2 ...... a matched case-control study.

@en

Urinary 8-iso-prostaglandin F2 ...... a matched case-control study.

@nl

P1433

Q44752430-D613DA13-4E6B-4AE8-B499-E00269667E48

P1476

Q44752430-B428D8CF-FEB4-48FE-ACD8-B986FFB8B347

P2093

Q44752430-03C7E6AD-1ADD-4C94-99A1-4F753DD5EA25

Q44752430-211CB7BF-342F-4AB9-ACDF-95AD4803AEFA

Q44752430-29533F80-97D6-4313-ACB5-F0F91DBC87ED

Q44752430-2A248378-316B-4EE4-B09A-CE2C6138683D

Q44752430-2DABBD13-C1EE-4B15-9972-6897F327B5AD

Q44752430-434E43CD-17C9-462F-B262-110141B87FEB

Q44752430-7A663294-FB03-4744-8DF3-F2ED5757D566

Q44752430-DB1A0B09-8BDC-456B-919B-6BD313DE31BF

Q44752430-E6DE3A79-ADBD-46B8-9416-E469D2C44D16

Q44752430-ED8AE8A8-5AC0-4A4F-B0CC-9DD39791BA3C

P304

Q44752430-FDB83527-5243-4113-999D-6D944BFFC457

P31

Q44752430-2EC471EE-21CB-4B0F-B258-8AA2BC4E3BE1

P356

Q44752430-3B8C82A8-6C0C-4D8C-93C9-9833F0A207B4

P407

Q44752430-4817D41B-060C-441C-8B10-8846A6D8FB61

P433

Q44752430-8F1F1A9C-4EF5-4A08-B47E-229D80697C7F

P478

Q44752430-ACF3E9DC-6C71-481E-93E2-E6E79CB72750

P50

Q44752430-B35A2A3D-A72F-4210-92AF-C1DAA1C277D4

P577

Q44752430-AF9CABA0-9220-4683-B3CD-5E54BFB7E8CE

P698

Q44752430-6E901037-EB01-437D-922D-87C1A14B963B

P356

01.CIR.0000116761.93647.30

P1433

P1476

Urinary 8-iso-prostaglandin F2 ...... a matched case-control study.

@en

P2093

Asja Bartling

http://www.w3.org/2001/XMLSchema#string

Dimitrios Tsikas

http://www.w3.org/2001/XMLSchema#string

Edzard Schwedhelm

http://www.w3.org/2001/XMLSchema#string

Frank-Mathias Gutzki

http://www.w3.org/2001/XMLSchema#string

Henrike Lenzen

http://www.w3.org/2001/XMLSchema#string

Jens Brümmer

http://www.w3.org/2001/XMLSchema#string

Jürgen Berger

http://www.w3.org/2001/XMLSchema#string

Jürgen C Frölich

http://www.w3.org/2001/XMLSchema#string

Rainer H Böger

http://www.w3.org/2001/XMLSchema#string

Renke Maas

http://www.w3.org/2001/XMLSchema#string

P304

843-848

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000116761.93647.30

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Edzard Schwedhelm

P577

2004-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14757688

http://www.w3.org/2001/XMLSchema#string